logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Journal Article
|Research

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim CS, Lak KK, Hak C, Dim B, Im Sin C, Sun S, Guillard B, Sar B, Vong S, Fernandez MAL, Fox L, Delfraissy JF, Goldfeld AE
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Tuberculosis remains an important cause of death among patients infected with the human immunodeficiency virus (HIV). Robust data are lacking with regard to the timing for the initiation of antiretroviral therapy (ART) in relation to the start of antituberculosis therapy.

Countries

Cambodia

Subject Area

tuberculosisHIV/AIDS

Languages

English
DOI
10.1056/NEJMoa1013911
Published Date
20 Oct 2011
PubMed ID
22010913
Journal
New England Journal of Medicine
Volume | Issue | Pages
Volume 365, Issue 16
Issue Date
2011-10-20
Dimensions Badge
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis | Journal Article / Research | MSF Science Portal